Yi ZM - Search Results

1

Impact of a Collaborative Pharmaceutical Care Service for Patients With Parkinson's Disease.

Yi ZM, Willis S, Zhang Y, Liu N, Tang QY, Zhai SD. Yi ZM, et al. Front Pharmacol. 2022 Jan 3;12:793361. doi: 10.3389/fphar.2021.793361. eCollection 2021. Front Pharmacol. 2022. PMID: 35046815 Free PMC article.

2

Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis.

Yi ZM, Liu F, Zhai SD. Yi ZM, et al. Int J Clin Pract. 2010 Aug;64(9):1310-7. doi: 10.1111/j.1742-1241.2010.02437.x. Int J Clin Pract. 2010. PMID: 20653802 Review.

3

Off-label prescriptions for adult neurological patients: a pilot survey in China.

Yi ZM, Zhai SD, Huang S, Wang TS, Liu F. Yi ZM, et al. Int J Clin Pharm. 2012 Feb;34(1):81-7. doi: 10.1007/s11096-011-9590-2. Epub 2011 Dec 16. Int J Clin Pharm. 2012. PMID: 22173814

4

Comparison of U.S. and Chinese pharmacy education programs.

Yi ZM, Zhao RS, Zhai SD, Yang L, Hu YF, Yang YH, Zhang X, Tracy TS. Yi ZM, et al. Am J Health Syst Pharm. 2014 Mar 1;71(5):425-9. doi: 10.2146/ajhp130611. Am J Health Syst Pharm. 2014. PMID: 24534598 No abstract available.

5

Identify practice gaps in medication education through surveys to patients and physicians.

Yi ZM, Zhi XJ, Yang L, Sun SS, Zhang Z, Sun ZM, Zhai SD. Yi ZM, et al. Patient Prefer Adherence. 2015 Oct 9;9:1423-30. doi: 10.2147/PPA.S93219. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26557752 Free PMC article.

6

An evaluation of clinical pharmacist service on a neurology care unit.

Yi ZM, Sun SS, Li XX, Lu M, Zhai SD. Yi ZM, et al. Int J Clin Pharm. 2016 Feb;38(1):30-3. doi: 10.1007/s11096-015-0224-y. Epub 2015 Dec 10. Int J Clin Pharm. 2016. PMID: 26659084

7

Comparison of prophylactic effect of UGIB and effects on platelet function between PPIs and H₂RAs combined with DAPT: systematic review and meta-analysis.

Yi ZM, Qiu TT, Zhang Y, Liu ZY, Zhai SD. Yi ZM, et al. Ther Clin Risk Manag. 2017 Mar 24;13:367-377. doi: 10.2147/TCRM.S127292. eCollection 2017. Ther Clin Risk Manag. 2017. PMID: 28392699 Free PMC article.

8

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation.

Yi ZM, Qiu TT, Zhang Y, Liu N, Zhai SD. Yi ZM, et al. Ther Clin Risk Manag. 2018 Apr 16;14:709-719. doi: 10.2147/TCRM.S163190. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 29713179 Free PMC article.

9

Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis.

Men P, Yi Z, Li C, Qu S, Xiong T, Yu X, Zhai S. Men P, et al. BMC Psychiatry. 2018 Sep 5;18(1):286. doi: 10.1186/s12888-018-1867-8. BMC Psychiatry. 2018. PMID: 30185173 Free PMC article.

10

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles.

Yi ZM, -, Wen C, Cai T, Xu L, Zhong XL, Zhan SY, Zhai SD. Yi ZM, et al. Neuropsychiatr Dis Treat. 2018 Dec 17;15:1-19. doi: 10.2147/NDT.S181886. eCollection 2019. Neuropsychiatr Dis Treat. 2018. PMID: 30587993 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters